Traders should watch for potential downward pressure on NUVL shares, particularly given the CEO's large sale immediately following option exercises. This pattern may signal lack of confidence in near-term upside, especially in a high-growth biotech where executives typically hold long-term equity. Monitor upcoming earnings or pipeline updates for catalysts that could justify or counter this selling.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 31 $102.45entry
- T+1 · 8mo ago +3.11%α +2.36% · $105.64
- T+5 · 7mo ago +2.53%α −1.42% · $105.04
- T+20 · 7mo ago −3.27%α −12.69% · $99.10
- T+60 · 5mo ago +20.57%α +8.47% · $123.52
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Nuvalent CEO and CFO sold shares worth $1.79M in a coordinated cluster over the past week, with the CEO selling $1.17M and exercising options worth $259K. The transactions represent a material insider selling event involving top leadership.
Key Financial Metrics
Key Facts
- CEO James Richard Porter sold 11,354 shares for $1.17M and exercised 27,428 derivative shares (two tranches of 13,714) at $18.93, realizing $259,606 in value.
- CFO Alexandra Balcom sold 3,500 shares for $370,365.
- Chief Development Officer Darlene Noci sold 2,500 shares for $247,000.
- Total open-market sales: $1.79M over a 7-day window, representing ~0.022% of $8.0B market cap.
- All three transactions were reported under Form 4 with code 'S' (open-market sale).
Financial Impact
$1.79M in net insider selling over 7 days
Risk Factors
- Insider selling concentrated among C-suite executives, including CEO and CFO, increasing signal strength.
- Risk of negative market perception around equity monetization after stock run-up, potentially dampening investor sentiment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NUVL-1775680253361 |
Track record
18 reports on NUVL
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +21.01% at T+60 after the Apr 7, 2026 report. 3 of 7 went positive at some point.
Filters
- Jul 27, 202616w ago 15-12G Neutral 3/10 No price data
- Jul 15, 202617w ago 25-NSE Neutral 3/10 Entry $123.96 No price data
- Jul 15, 202617w ago 8-K Bullish 5/10 Entry $123.96 No price data
- Jul 8, 202618w ago Insider Cluster Neutral 3/10 Entry $123.80 No price data
- Jul 6, 202619w ago Insider Cluster Neutral 3/10 Entry $123.72 No price data
- Jun 11, 202622w ago Insider Cluster Neutral 2/10 Entry $123.25 to $123.90 ▲ +0.53% −1.25% vs SPY
- Jun 10, 202622w ago Insider Cluster Neutral 3/10 Entry $123.45 to $123.83 ▲ +0.31% −1.58% vs SPY
- Jun 9, 202622w ago 8-K Bullish 8/10 Entry $123.25 to $123.77 ▲ +0.42% −1.02% vs SPY
- May 7, 202627w ago 8-K Neutral 4/10 Entry $102.40 to $90.18 ▼ −11.93% −15.07% vs SPY
- Apr 29, 202628w ago Insider Cluster Neutral 2/10 Entry $99.10 to $107.38 ▲ +8.36% +2.90% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers